IOM Report Lists Comparative Effectiveness Priorities

The Institute of Medicine has laid out priority areas including some genomics and biomarker-focused studies that the stimulus funding should support.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.